SUPN Supernus Pharmaceuticals
- 36.140
- +0.040+0.11%
- 36.140
- 0.0000.00%
Supernus Pharmaceuticals所有資訊
Supernus Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Armistice Capital, LLC(9.25%),Steven Boyd(9.25%)
Supernus Pharmaceuticals | 4：持股變動聲明-董事 NEWHALL CHARLES W III
Supernus Pharmaceuticals | 4：持股變動聲明-董事 Hudson Frederick M.
Supernus Pharmaceuticals | 4：持股變動聲明-董事 GEMAYEL GEORGES
Supernus Pharmaceuticals | 4：持股變動聲明-高管 Khattar Jack A.
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 4：持股變動聲明-高管 Mottola Frank
Supernus Pharmaceuticals | 4：持股變動聲明-高管 Khattar Jack A.
Supernus Pharmaceuticals | 4：持股變動聲明-董事 GEMAYEL GEORGES
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 144：擬議出售證券
Supernus Pharmaceuticals | 10-Q：2024財年三季報
Supernus Pharmaceuticals | 8-K：Supernus 公佈2024年第三季度財務業績
Supernus Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Macquarie Group Limited(4.78%),Macquarie Management Holdings Inc(4.78%)等
Supernus Pharmaceuticals | SC 13G：超過5%持股股東披露文件-Dimensional Fund Advisors LP(5.2%)
Supernus Pharmaceuticals | 8-K：重大事件
分析
目標價預測
暫無數據
暫無數據